Bellecapital International Ltd. Eli Lilly & CO Transaction History

Bellecapital International Ltd.

$471 Million
Q1 2025

A detailed history of Bellecapital International Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Bellecapital International Ltd. holds 2,001 shares of LLY stock, worth $1.59 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

2,001

Previous 2,219 9.82%

Holding current value

$1.59 Million

Previous $1.71 Million 3.56%

% of portfolio

0.35%

Previous 0.33%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	SELL	$725.72 - $929.72 $158,206 - $202,678	-218 Reduced 9.82%	2,001 $1.65 Million
Q4 2024 Feb 06, 2025	BUY	$727.2 - $932.06 $109,080 - $139,809	150 Added 7.25%	2,219 $1.71 Million
Q3 2024 Oct 21, 2024	SELL	$772.14 - $960.02 $786,810 - $978,260	-1,019 Reduced 33.0%	2,069 $1.83 Million
Q2 2024 Jul 19, 2024	SELL	$724.87 - $909.04 $527,705 - $661,781	-728 Reduced 19.08%	3,088 $2.8 Million
Q4 2023 Jan 22, 2024	BUY	$525.19 - $619.13 $35,712 - $42,100	68 Added 1.81%	3,816 $2.22 Million
Q3 2023 Oct 17, 2023	SELL	$434.7 - $599.3 $393,838 - $542,965	-906 Reduced 19.47%	3,748 $2.01 Million
Q2 2023 Jul 07, 2023	SELL	$350.74 - $468.98 $106,975 - $143,038	-305 Reduced 6.15%	4,654 $2.18 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $77,493 - $90,295	-241 Reduced 4.63%	4,959 $1.81 Million
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $25,793 - $29,394	-87 Reduced 1.65%	5,200 $1.68 Million
Q2 2022 Jul 27, 2022	SELL	$278.73 - $327.27 $11,985 - $14,072	-43 Reduced 0.81%	5,287 $1.71 Million
Q4 2021 Jan 20, 2022	SELL	$224.85 - $279.04 $4,946 - $6,138	-22 Reduced 0.41%	5,330 $1.47 Million
Q1 2021 Apr 13, 2021	SELL	$164.32 - $212.72 $17,582 - $22,761	-107 Reduced 1.96%	5,352 $1 Million
Q4 2020 Jan 14, 2021	SELL	$130.46 - $172.63 $9,784 - $12,947	-75 Reduced 1.36%	5,459 $922,000
Q3 2020 Oct 16, 2020	BUY	$146.22 - $169.13 $62,874 - $72,725	430 Added 8.42%	5,534 $819,000
Q1 2020 Apr 24, 2020	BUY	$119.05 - $147.35 $28,095 - $34,774	236 Added 4.85%	5,104 $708,000
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $46,082 - $57,077	-431 Reduced 8.13%	4,868 $640,000
Q3 2019 Oct 22, 2019	SELL	$106.79 - $116.16 $7,475 - $8,131	-70 Reduced 1.3%	5,299 $593,000
Q2 2019 Jul 22, 2019	BUY	$110.79 - $129.32 $27,697 - $32,330	250 Added 4.88%	5,369 $595,000
Q1 2019 Apr 23, 2019	BUY	$111.31 - $131.02 $133,794 - $157,486	1,202 Added 30.69%	5,119 $664,000
Q4 2018 Feb 07, 2019	BUY	$105.9 - $118.64 $139,258 - $156,011	1,315 Added 50.54%	3,917 $453,000
Q4 2017 Feb 06, 2018	BUY	$81.94 - $87.89 $213,207 - $228,689	2,602	2,602 $220,000

Others Institutions Holding LLY

# of Institutions

4,395

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bellecapital International Ltd. with notifications on news.

Account

Bellecapital International Ltd. Eli Lilly & CO Transaction History